-
Something wrong with this record ?
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
S. Drápela, J. Bouchal, MK. Jolly, Z. Culig, K. Souček,
Language English Country Switzerland
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2014
Free Medical Journals
from 2014
PubMed Central
from 2014
Europe PubMed Central
from 2014
Open Access Digital Library
from 2014-01-01
Open Access Digital Library
from 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2014
- Publication type
- Journal Article MeSH
- Review MeSH
The predominant way in which conventional chemotherapy kills rapidly proliferating cancer cells is the induction of DNA damage. However, chemoresistance remains the main obstacle to therapy effectivity. An increasing number of studies suggest that epithelial-to-mesenchymal transition (EMT) represents a critical process affecting the sensitivity of cancer cells to chemotherapy. Zinc finger E-box binding homeobox 1 (ZEB1) is a prime element of a network of transcription factors controlling EMT and has been identified as an important molecule in the regulation of DNA damage, cancer cell differentiation, and metastasis. Recent studies have considered upregulation of ZEB1 as a potential modulator of chemoresistance. It has been hypothesized that cancer cells undergoing EMT acquire unique properties that resemble those of cancer stem cells (CSCs). These stem-like cells manifest enhanced DNA damage response (DDR) and DNA repair capacity, self-renewal, or chemoresistance. In contrast, functional experiments have shown that ZEB1 induces chemoresistance regardless of whether other EMT-related changes occur. ZEB1 has also been identified as an important regulator of DDR by the formation of a ZEB1/p300/PCAF complex and direct interaction with ATM kinase, which has been linked to radioresistance. Moreover, ATM can directly phosphorylate ZEB1 and enhance its stability. Downregulation of ZEB1 has also been shown to reduce the abundance of CHK1, an effector kinase of DDR activated by ATR, and to induce its ubiquitin-dependent degradation. In this perspective, we focus on the role of ZEB1 in the regulation of DDR and describe the mechanisms of ZEB1-dependent chemoresistance.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019439
- 003
- CZ-PrNML
- 005
- 20230119094531.0
- 007
- ta
- 008
- 201103s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fmolb.2020.00036 $2 doi
- 035 __
- $a (PubMed)32266287
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Drápela, Stanislav $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia. International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital in Brno, Brno, Czechia. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia. $7 xx0280838
- 245 10
- $a ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance / $c S. Drápela, J. Bouchal, MK. Jolly, Z. Culig, K. Souček,
- 520 9_
- $a The predominant way in which conventional chemotherapy kills rapidly proliferating cancer cells is the induction of DNA damage. However, chemoresistance remains the main obstacle to therapy effectivity. An increasing number of studies suggest that epithelial-to-mesenchymal transition (EMT) represents a critical process affecting the sensitivity of cancer cells to chemotherapy. Zinc finger E-box binding homeobox 1 (ZEB1) is a prime element of a network of transcription factors controlling EMT and has been identified as an important molecule in the regulation of DNA damage, cancer cell differentiation, and metastasis. Recent studies have considered upregulation of ZEB1 as a potential modulator of chemoresistance. It has been hypothesized that cancer cells undergoing EMT acquire unique properties that resemble those of cancer stem cells (CSCs). These stem-like cells manifest enhanced DNA damage response (DDR) and DNA repair capacity, self-renewal, or chemoresistance. In contrast, functional experiments have shown that ZEB1 induces chemoresistance regardless of whether other EMT-related changes occur. ZEB1 has also been identified as an important regulator of DDR by the formation of a ZEB1/p300/PCAF complex and direct interaction with ATM kinase, which has been linked to radioresistance. Moreover, ATM can directly phosphorylate ZEB1 and enhance its stability. Downregulation of ZEB1 has also been shown to reduce the abundance of CHK1, an effector kinase of DDR activated by ATR, and to induce its ubiquitin-dependent degradation. In this perspective, we focus on the role of ZEB1 in the regulation of DDR and describe the mechanisms of ZEB1-dependent chemoresistance.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bouchal, Jan $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czechia.
- 700 1_
- $a Jolly, Mohit Kumar $u Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore, India.
- 700 1_
- $a Culig, Zoran $u International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital in Brno, Brno, Czechia. Department of Urology, Experimental Urology, Innsbruck Medical University, Innsbruck, Austria.
- 700 1_
- $a Souček, Karel $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia. International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital in Brno, Brno, Czechia. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
- 773 0_
- $w MED00188065 $t Frontiers in molecular biosciences $x 2296-889X $g Roč. 7, č. - (2020), s. 36
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32266287 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20230119094524 $b ABA008
- 999 __
- $a ind $b bmc $g 1586216 $s 1109637
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 7 $c - $d 36 $e 20200319 $i 2296-889X $m Frontiers in molecular biosciences $n Front Mol Biosci $x MED00188065
- LZP __
- $a Pubmed-20201103